Amyloidosis Clinical Trials

160 clinical trials for Amyloidosis across international registries, including 44 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant — RECRUITING · PHASE3
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis — RECRUITING · PHASE4
• A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis — RECRUITING · PHASE2
• A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis. — RECRUITING · PHASE1
• Dietary Reporting In The Amyloidoses — RECRUITING · NA
• Prevalence and Significance of ATTR Aortic Valve Amyloidosis in Degenerative Aortic Stenosis — RECRUITING · NA
• Validation of novel ECG Parameters to detect Fabry disease and other cardiomyopathies — RECRUITING
• Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load — RECRUITING · PHASE1
• Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis — RECRUITING · PHASE1
• NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis — RECRUITING
• A Phase 3 Study of NTLA-2001 in ATTRv-PN — RECRUITING · PHASE3
• Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis — RECRUITING · PHASE2
• BE.Amycon Biobank & Data Registry UZ Leuven — RECRUITING
• Follow-up of patients with transthyretin amyloid cardiomyopathy by multi-modality imaging — RECRUITING
• A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA) — RECRUITING · PHASE3
• Complications, risks and diagnostic significance of endomyocardial biopsies for the diagnosis of cardiomyopathies in children and adolescents — RECRUITING
• Amyloidosis register ACCB — RECRUITING
• Institutional Registry of Rare Diseases — RECRUITING
• Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE) — RECRUITING · PHASE2
• A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography — RECRUITING
• Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis — RECRUITING
• A Study Of MCG In Cardiac Amyloidosis — RECRUITING
• AI-assisted multimodal differential diagnosis in diseases with myocardial thickening — RECRUITING
• Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry — RECRUITING
• Prevalence of Amyloidosis in Trauma Patients — RECRUITING
• Registry for Adults With Plasma Cell Disorders (PCD's) — RECRUITING
• [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis — RECRUITING
• National Clinical Amyloidosis Registry — RECRUITING
• A PHASE 1B/2 STUDY OF AZD0120 (ALSO KNOWN AS GC012F), A CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY TARGETING CD19 AND B-CELL MATURATION ANTIGEN (BCMA) IN PARTICIPANTS WITH RELAPSED OR REFRACTORY AL AMYLOIDOSIS — RECRUITING · PHASE1
• Pan-Amyloid PET/CT in Various Amyloid-Related Disease — RECRUITING
• Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause. — RECRUITING · NA
• Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF — RECRUITING · NA
• FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases — RECRUITING
• A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND PHARMACODYNAMICS OF INTRATHECALLY ADMINISTERED ALN-APP IN PATIENTS WITH CEREBRAL AMYLOID ANGIOPATHY (CAA) — RECRUITING · PHASE2
• DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies — RECRUITING
• A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH — RECRUITING
• A PHASE 2, MULTICOHORT STUDY OF DARATUMUMAB-BASED THERAPIES IN PARTICIPANTS WITH AMYLOID LIGHT CHAIN (AL) AMYLOIDOSIS — RECRUITING · PHASE2
• A PHASE 3, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF BIRTAMIMAB PLUS STANDARD OF CARE VS. PLACEBO PLUS STANDARD OF CARE IN MAYO STAGE IV SUBJECTS WITH LIGHT CHAIN (AL) AMYLOIDOSIS — RECRUITING · PHASE3
• A PHASE 3, DOUBLE-BLIND, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CAEL-101 AND PLASMA CELL DYSCRASIA TREATMENT VERSUS PLACEBO AND PLASMA CELL DYSCRASIA TREATMENT IN PLASMA CELL DYSCRASIA TREATMENT-NAÏVE PATIENTS WITH MAYO STAGE IIIA AL AMYLOIDOSIS — RECRUITING · PHASE3
• A PHASE 3, DOUBLE-BLIND, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CAEL-101 AND PLASMA CELL DYSCRASIA TREATMENT VERSUS PLACEBO AND PLASMA CELL DYSCRASIA TREATMENT IN PLASMA CELL DYSCRASIA TREATMENT-NAÏVE PATIENTS WITH MAYO STAGE IIIB AL AMYLOIDOSIS — RECRUITING · PHASE3
• A RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DARATUMUMAB IN COMBINATION WITH CYCLOPHOSPHAMIDE, BORTEZOMIB AND DEXAMETHASONE (CYBORD) COMPARED WITH CYBORD ALONE IN NEWLY DIAGNOSED SYSTEMIC AL AMYLOIDOSIS — RECRUITING · PHASE3
• A PHASE 3, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-ARM, EFFICACY AND SAFETY STUDY OF NEOD001 PLUS STANDARD OF CARE VS PLACEBO PLUS STANDARD OF CARE IN SUBJECTS WITH LIGHT CHAIN (AL) AMYLOIDOSIS — RECRUITING · PHASE3
• PHASE I STUDY OF POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE (PVD) AS FIRST-LINE TREATMENT OF AL AMYLOIDOSIS OR LIGHT CHAIN DEPOSITION DISEASE — RECRUITING · PHASE1
• Carpal Tunnel Release With Risk Factors for Amyloidosis — COMPLETED · NA
• To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) — NOT_YET_RECRUITING · PHASE3
• HIBA-Institutional Registry of Amyloidosis — COMPLETED
• A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis — ACTIVE_NOT_RECRUITING · PHASE2
• Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in Russia — COMPLETED
• Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial — ACTIVE_NOT_RECRUITING · NA

Refine this search